Dr. Zaman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12502 Willowbrook Rd
Suite 580
Cumberland, MD 21502Phone+1 301-777-3111Fax+1 301-777-0963
Education & Training
University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 1980 - 1982
UPMC Medical Education/McKeesport HospitalResidency, Internal Medicine, 1977 - 1980- UPMC Medical EducationInternship, Transitional Year, 1976 - 1977
King Edward Medical UniversityClass of 1972
Certifications & Licensure
MD State Medical License 1979 - 2025
WV State Medical License 1984 - 2009
PA State Medical License 1979 - 1990
FL State Medical License 1982 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Publications & Presentations
PubMed
- 4 citationsTeenage mutant neutrophilic precursors: Leukemia cutis with IDH2 mutation on enasidenib therapy.Michael E. Kallen, Rima Koka, Zeba N. Singh, Gabriela Sanchez-Petitto, Qamar U Zaman
Leukemia Research. 2020-06-25
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
